Dividendes sectoriels Enliven Therapeutics, Inc.
Actions
ELVN
US29337E1029
Recherche biotechnologique et médicale
|
Marché Fermé -
Nasdaq
22:00:00 23/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 46,09 USD | -4,36% |
|
-6,17% | +199,29% |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Rendement du dividende (Y) | Rendement du dividende (Y+1) | PER (Y) | Price to Book (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
| - | - | -26.03x | - | - | -21.77x | -21.05x | 3,38 Md | ||
| 1,36% | 1,49% | 21.8x | 5.14x | 7.74x | 15.55x | 17.59x | 74,18 Md | ||
| 0,04% | 0,08% | 31.81x | 6.27x | 9.18x | 28.6x | 29.13x | 59,55 Md | ||
| -.--% | -.--% | -73.75x | 37.01x | 14.26x | -68.76x | -82.35x | 25,84 Md | ||
| -.--% | -.--% | -15.46x | 1.26x | 5.96x | -7.5x | -5.91x | 24,73 Md | ||
| -.--% | -.--% | 28.48x | 3.39x | 5.36x | 17.82x | 19.98x | 20,87 Md | ||
| 0,34% | 0,2% | 43.75x | 10.89x | 16.03x | 32.53x | 35.13x | 15,32 Md | ||
| -.--% | -.--% | 17.96x | 5.53x | 5.35x | 12.5x | 13.25x | 14,06 Md | ||
| -.--% | -.--% | -14.82x | 50.72x | 3341.5x | -17.09x | -14.67x | 13,12 Md | ||
| -.--% | -.--% | -82.17x | 26.7x | 7.51x | -62.2x | -60.88x | 11,85 Md | ||
| -.--% | -.--% | -19.74x | 26.06x | 20.2x | -21.97x | -19.52x | 9,46 Md | ||
| -.--% | -.--% | -11.04x | -70.85x | 54.98x | -11.47x | -11.25x | 9,15 Md | ||
| -.--% | -.--% | -7.05x | - | - | -7.29x | -6.75x | 8,41 Md | ||
| -.--% | -.--% | -31.43x | 8.26x | - | -27.68x | -28.56x | 7,77 Md | ||
| 0,15% | 0,24% | 54.17x | 1.73x | 3.78x | 17.19x | 33.56x | 6,68 Md | ||
| -.--% | -.--% | -38.6x | 6.64x | - | -27.65x | -27.81x | 5,95 Md | ||
| -.--% | -.--% | -15.63x | 23.54x | 903.13x | -13.79x | -13.57x | 6,07 Md | ||
| Moyenne | 0,12% | 0,13% | -8,10x | 9,49x | 338,08x | -9,59x | -8,45x | 18,61 Md | |
| Moyenne pondérée par Capi. | 0,35% | 0,38% | 2,94x | 9,51x | 179,49x | 0,58x | 1,05x |
- Bourse
- Actions
- Action ELVN
- Secteur Enliven Therapeutics, Inc.
- Dividendes sectoriels
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















